New and unusual infections in neutropenic patients.
Infections in immunocompromised patients with cancer are common and the primary risk factor is neutropenia, usually induced by chemotherapeutic agents. The spectrum of bacterial infection is shifting from gram-negative to gram-positive. The array of fungal infections in cancer patients is expanding to include organisms previously unknown as invasive human pathogens. New species are being defined to explain extant pathologies, and free living algae are now emerging as pathogens in immunocompromised patients. Physicians must remain alert to these emerging pathogens and to the need to evaluate optimal treatments for the usual and unusual infections in neutropenic and other compromised patients with cancer and allied diseases.
Zinner
S H
SH
Divisions of Infectious Diseases, Brown University School of Medicine, Providence, RI 02908-4735, USA.
D001421:Bacteria, Anaerobic / Q000302:isolation & purification; D016905:Gram-Negative Bacterial Infections / Q000517:prevention & control; D006801:Humans; D009164:Mycobacterium Infections / Q000517:prevention & control; D009181:Mycoses / Q000517:prevention & control; D009369:Neoplasms / Q000097:blood / Q000150:complications*; D009503:Neutropenia / Q000150:complications*; D009894:Opportunistic Infections / Q000150:complications / Q000517:prevention & control*; D014777:Virus Diseases / Q000517:prevention & control